Cause of death, by non-communicable diseases, ages 0-4, female in Uruguay
Uruguay: Cause of death, by non-communicable diseases, ages 0-4, female was 42.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Uruguay, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
Uruguay recorded 42.5% for cause of death, by non-communicable diseases, ages 0-4, female in 2021.
The figure is down 2.8% on the previous year and down 1.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Uruguay peaked at 46.0% in 2015 and was at its lowest, 37.4%, in 2000.
Uruguay ranks 34th of 185 countries on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 0-4, female in Uruguay, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 37.4% | — |
| 2010 | 43.4% | +15.9% |
| 2015 | 46.0% | +6.2% |
| 2019 | 43.2% | -6.2% |
| 2020 | 43.8% | +1.3% |
| 2021 | 42.5% | -2.8% |
Uruguay compared with similar countries
- Uruguay's 42.5% is below the median for high income countries, which is 42.8%, 99% of the median. (58 countries reporting)
- Uruguay's 42.5% is above the median for Latin America & Caribbean, which is 30.9%, 1.4× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.4% | 37.4% | 37.4% | 1 |
| 2010s | 44.2% | 43.2% | 46.0% | 3 |
| 2020s | 43.2% | 42.5% | 43.8% | 2 |
Countries ranked near Uruguay
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Uruguay?
- Cause of death, by non-communicable diseases, ages 0-4, female in Uruguay was 42.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Uruguay?
- The highest recorded value was 46.0% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Uruguay?
- The lowest recorded value was 37.4% in 2000.
- How does Uruguay rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Uruguay ranks 34th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Uruguay?
- Over the last ten years it is down 1.9%. The long-run trend across the full record is rising.
- Where does this Uruguay data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.